Article

Depression Linked to Sleep Apnea

Author(s):

Excessive daytime sleepiness related to severe obstructive sleep apnea is also linked to depression in men, reported a team of researchers from Australia.

Excessive daytime sleepiness related to severe obstructive sleep apnea is also linked to depression in men, reported a team of researchers from Australia.

In an abstract presented at the 2015 American Thoracic Society meeting in Denver, CO, Carol Lang, PHD of the University of Adelaide, Australia and colleagues said they looked at a group of 1,875 men ages 35 to 83 who had been assessed for depression during a 5-year period.

From that group they selected a random sample of 857 men who did not have previously diagnosed obstructive sleep apnea (OSA). As controls they also included 1,660 men without depression.

The subjects had at-home polysomnography and completed the Epworth Sleepiness Scale questionnaire.

After adjusting for potential confounders, the researchers found severe OSA was associated with an increased prevalence of depression and that men who had both previously undiagnosed OSA and excessive daytime sleepiness had a 4 to 5 times greater chance of being depressed.

“Men presenting with depression should be screened for OSA so that appropriate course of treatment can be planned,” Lang concluded.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
© 2024 MJH Life Sciences

All rights reserved.